165 related articles for article (PubMed ID: 36245230)
41. Development of a human antibody fragment directed against the alpha folate receptor as a promising molecule for targeted application.
Parakasikron N; Chaotham C; Chanvorachote P; Vinayanuwattikun C; Buranasudja V; Taweecheep P; Khantasup K
Drug Deliv; 2021 Dec; 28(1):1443-1454. PubMed ID: 34236266
[TBL] [Abstract][Full Text] [Related]
42. Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications.
Hulin-Curtis SL; Davies JA; Nestić D; Bates EA; Baker AT; Cunliffe TG; Majhen D; Chester JD; Parker AL
Cancer Gene Ther; 2020 Nov; 27(10-11):785-798. PubMed ID: 31902944
[TBL] [Abstract][Full Text] [Related]
43. Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system.
Machida H; Matsuo K; Kobayashi Y; Momomura M; Takahashi F; Tabata T; Kondo E; Yamagami W; Ebina Y; Kaneuchi M; Nagase S; Mikami M
J Gynecol Oncol; 2022 May; 33(3):e26. PubMed ID: 35320882
[TBL] [Abstract][Full Text] [Related]
44. Folate Receptor α Expression Level Correlates With Histologic Grade in Lung Adenocarcinoma.
Driver BR; Barrios R; Ge Y; Haque A; Tacha D; Cagle PT
Arch Pathol Lab Med; 2016 Jul; 140(7):682-5. PubMed ID: 26599808
[TBL] [Abstract][Full Text] [Related]
45. Super-resolution imaging of folate receptor alpha on cell membranes using peptide-based probes.
Jing Y; Huang L; Dong Z; Gong Z; Yu B; Lin D; Qu J
Talanta; 2024 Feb; 268(Pt 1):125286. PubMed ID: 37832456
[TBL] [Abstract][Full Text] [Related]
46. Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers.
Zuo S; Wen Y; Panha H; Dai G; Wang L; Ren X; Fu K
Mol Immunol; 2017 May; 85():293-304. PubMed ID: 28360017
[TBL] [Abstract][Full Text] [Related]
47. Protein-Labeling Fluorescent Probe for Folate Receptor α.
Fang PW; Lin YC; Fan SY; Panja A; Xu SQ; Lee SH; Tan KT
Anal Chem; 2023 Aug; 95(30):11535-11541. PubMed ID: 37479992
[TBL] [Abstract][Full Text] [Related]
48. Fourth-generation chimeric antigen receptor T cells targeting folate receptor alpha antigen expressed on breast cancer cells for adoptive T cell therapy.
Luangwattananun P; Junking M; Sujjitjoon J; Wutti-In Y; Poungvarin N; Thuwajit C; Yenchitsomanus PT
Breast Cancer Res Treat; 2021 Feb; 186(1):25-36. PubMed ID: 33389403
[TBL] [Abstract][Full Text] [Related]
49. Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study.
Azaïs H; Schmitt C; Tardivel M; Kerdraon O; Stallivieri A; Frochot C; Betrouni N; Collinet P; Mordon S
Photodiagnosis Photodyn Ther; 2016 Mar; 13():130-138. PubMed ID: 26200606
[TBL] [Abstract][Full Text] [Related]
50. Differential expression of folate receptor alpha in pituitary adenomas and its relationship to tumor behavior.
Liu X; Ma S; Yao Y; Li G; Feng M; Deng K; Dai C; Cai F; Li Y; Zhang B; Wang R
Neurosurgery; 2012 May; 70(5):1274-80; discussion 1280. PubMed ID: 22089756
[TBL] [Abstract][Full Text] [Related]
51. Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles.
Akbarian A; Ebtekar M; Pakravan N; Hassan ZM
Int J Biol Macromol; 2020 Jun; 152():90-101. PubMed ID: 32057865
[TBL] [Abstract][Full Text] [Related]
52. Folate Receptor Overexpression in Human and Canine Meningiomas-Immunohistochemistry and Case Report of Intraoperative Molecular Imaging.
Pierce JT; Cho SS; Nag S; Zeh R; Jeon J; Holt D; Durham A; Nasrallah MP; Singhal S; Lee JYK
Neurosurgery; 2019 Sep; 85(3):359-368. PubMed ID: 30113687
[TBL] [Abstract][Full Text] [Related]
53. Quantitation of rare circulating tumor cells by folate receptor α ligand-targeted PCR in bladder transitional cell carcinoma and its potential diagnostic significance.
Qi F; Liu Y; Zhao R; Zou X; Zhang L; Li J; Wang Y; Li F; Zou X; Xia Y; Wang X; Xing L; Li C; Lu J; Tang J; Zhou F; Liu C; Gui Y; Cai Z; Sun X
Tumour Biol; 2014 Jul; 35(7):7217-23. PubMed ID: 24771263
[TBL] [Abstract][Full Text] [Related]
54. Activation of cytotoxic T lymphocytes by self-differentiated myeloid-derived dendritic cells for killing breast cancer cells expressing folate receptor alpha protein.
Luangwattananun P; Chiraphapphaiboon W; Thuwajit C; Junking M; Yenchitsomanus PT
Bioengineered; 2022 Jun; 13(6):14188-14203. PubMed ID: 35734827
[TBL] [Abstract][Full Text] [Related]
55. Folate Receptor Near-Infrared Optical Imaging Provides Sensitive and Specific Intraoperative Visualization of Nonfunctional Pituitary Adenomas.
Cho SS; Zeh R; Pierce JT; Jeon J; Nasrallah M; Adappa ND; Palmer JN; Newman JG; White C; Kharlip J; Snyder P; Low P; Singhal S; Grady MS; Lee JYK
Oper Neurosurg (Hagerstown); 2019 Jan; 16(1):59-70. PubMed ID: 29635300
[TBL] [Abstract][Full Text] [Related]
56. Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-
Hou Z; Gattoc L; O'Connor C; Yang S; Wallace-Povirk A; George C; Orr S; Polin L; White K; Kushner J; Morris RT; Gangjee A; Matherly LH
Mol Cancer Ther; 2017 May; 16(5):819-830. PubMed ID: 28138029
[TBL] [Abstract][Full Text] [Related]
57. Promising Nanocarriers for PEDF Gene Targeting Delivery to Cervical Cancer Cells Mediated by the Over-expressing FRα.
Yang Y; He L; Liu Y; Xia S; Fang A; Xie Y; Gan L; He Z; Tan X; Jiang C; Tong A; Song X
Sci Rep; 2016 Aug; 6():32427. PubMed ID: 27576898
[TBL] [Abstract][Full Text] [Related]
58. Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer.
Wen Y; Graybill WS; Previs RA; Hu W; Ivan C; Mangala LS; Zand B; Nick AM; Jennings NB; Dalton HJ; Sehgal V; Ram P; Lee JS; Vivas-Mejia PE; Coleman RL; Sood AK
Clin Cancer Res; 2015 Jan; 21(2):448-59. PubMed ID: 25416196
[TBL] [Abstract][Full Text] [Related]
59. Rationale for folate receptor alpha targeted therapy in "high risk" endometrial carcinomas.
Brown Jones M; Neuper C; Clayton A; Mariani A; Konecny G; Thomas MB; Keeney G; Hartmann L; Podratz KC
Int J Cancer; 2008 Oct; 123(7):1699-703. PubMed ID: 18646191
[TBL] [Abstract][Full Text] [Related]
60. Folate receptor-α targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study.
Boogerd LSF; Hoogstins CES; Gaarenstroom KN; de Kroon CD; Beltman JJ; Bosse T; Stelloo E; Vuyk J; Low PS; Burggraaf J; Vahrmeijer AL
Oncotarget; 2018 Jan; 9(1):791-801. PubMed ID: 29416655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
